A Phase III Study of Regional Radiation Therapy in Early Breast Cancer

Radiotherapy to the breast reduces the risk of cancer coming back for women with early breast cancer. This international study will determine if treating a larger area with radiotherapy can further improve the results.

Primary Sponsor

NCIC CTG

Collaborating Groups

Trans Tasman Radiation Oncology Group (TROG)

Final Accrual

180

Trial Chairperson

International: Prof Timothy J. Whelan
TROG: A/Prof Boon Chua

Trial Contact

ymurray@ctg.queensu.ca

Clinical Trial Registration

Related Post

22 June, 2026

Novel lung cancer radiation therapy approach to be tested in new PRIME-Lung trial

LATEST NEWS: 22 June 2026 In an important step

Facility Alliance Member in Focus
17 June, 2026

TROG Facility Alliance Member in Focus: Radiation Oncology Network, Western Sydney Local Health District

TROG’s Facility Alliance Members (FAM) are the cornerstone of